You can buy or sell AVDL and other stocks, options, ETFs, and crypto commission-free!
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. Read More The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.
52 Week High
52 Week Low
Seeking AlphaMay 8
Avadel Pharmaceuticals (AVDL) Interim CEO Greg Divis on Q1 2019 Results - Earnings Call Transcript
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2019 Earnings Conference Call May 8, 2019 8:30 AM ET Company Participants Greg Divis - Interim CEO Mike Kanan - CFO Jordon Dubow - CMO Geoff Glass - Chairman Conference Call Participants Operator Good morning, ladies and gentlemen, thank you for standing by. And welcome to the Avadel Pharmaceuticals’ First Quarter 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer s...
Yahoo FinanceMay 8
Introducing Avadel Pharmaceuticals (NASDAQ:AVDL), The Stock That Tanked 82%
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Even the best investor on earth makes unsuccessful investments. But it would be foolish to simply accept every extremely large loss as an inevitable part of the game. So spare a thought for the long term shareholders of Avadel Pharmaceuticals plc (NASDAQ:AVDL); the share price is down a whopping 82% in the last twelve months. A loss like this is a stark reminder that portfolio diversi...
-$0.44 per share
-$0.28 per share